> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Executive Order on Reducing Regulations Analyzed
- URL: https://www.fdaweb.com/executive-order-on-reducing-regulations-analyzed/
- Published: 2017-04-26T12:00:00.000Z
- Updated: 2026-09-14T22:19:54.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138556

A white paper issued by two Venable attorneys reviews President **Donald Trump**’s executive order on reducing regulations and controlling regulatory costs, saying it represents the greatest potential change in federal regulatory policy since a 1981 executive order issued by President **Ronald Reagan**. The [paper](http://www.lexology.com/library/detail.aspx?g=9935af48-98c8-4ebc-a227-9abf67321343&ref=fdaweb.com) explains what the order does and why it is so significant, highlights some of the implementation questions that remain open, and identifies some of the deregulatory opportunities it could create for stakeholders “that engage the administration in an ambitious and focused manner.”

The attorneys say that at its core, the order incentivizes agencies to find ways to cut costs, since taking deregulatory action that reduces overall costs “will provide the only path forward if they want to promulgate new rules that impose costs.” Several types of actions that they say could help agencies meet this goal include: 

- engaging in international regulatory cooperation, such as FDA’s mutual recognition agreement with the European Union;
- participating in developing and using international standards;
- using private sector conformity assessment;
- rules that expand consumption or production options; and
- reductions in paperwork and reporting burdens.

“The president’s new executive order on regulation could enable ambitious initiatives to eliminate unnecessary costs, including initiatives that would streamline regulation, permitting, and information collection, promote the use of private sector standards, and encourage U.S. regulators to engage in cooperation with their foreign counterparts as a normal course of business,” the attorneys conclude. “Strong and sustained engagement by the private sector with the administration, especially by providing specific reform ideas, backed up by data and analysis, will be essential to ensure that implementation of the order supports such initiatives.”